Mara Aspinall is a healthcare industry leader with experience in genetics, genomics, and diagnostics. She has held executive roles at Ventana Medical Systems and Genzyme, and co-founded BlueStone Venture Partners.
At firms with a similar stage, sector and check size.



One email when Mara's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckMara Aspinall is a healthcare industry leader with experience in genetics, genomics, and diagnostics. She has held executive roles at Ventana Medical Systems and Genzyme, and co-founded BlueStone Venture Partners.
Illumina Ventures has not reported a check size. It invests at seed, series a.
A warm intro from a founder Illumina Ventures backed works best.
president of Genzyme Genetics and Genzyme Pharmaceuticals at Genzyme Corporation; president and CEO at Ventana Medical Systems; BlueStone Venture Partners; co-founder and managing director at BlueStone Venture Partners.
Last updated 2026-10-15. Is this you? Ask for a correction.